文献速递冠心病外科

大隐静脉复合桥与动脉复合桥的10年造影和长期临床结局相当

Equivalent 10-year angiographic and long-term clinical outcomes with saphenous vein composite grafts and arterial composite grafts.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-04-08

该研究比较了基于左胸廓内动脉的大隐静脉复合桥与全动脉复合桥在非体外循环冠状动脉旁路移植术后的10年桥血管通畅率和长期临床结局。共纳入483例患者,其中SV组103例,ART组380例,倾向性评分匹配后各103例。中位随访128个月,结果显示两组在生存率、无心脏死亡、再干预、主要心脑血管不良事件及10年桥血管通畅率方面均无显著差异。

要点

  • 大隐静脉复合桥与全动脉复合桥的10年桥血管通畅率无显著差异
  • 两组长期临床结局(生存、再干预、MACCE)相似
  • 非体外循环CABG中,SV复合桥可作为动脉复合桥的等效选择

核心结论

  • 大隐静脉复合桥在10年桥血管通畅率和长期临床结局方面与动脉复合桥等效。

研究设计与样本

  • 回顾性队列研究,纳入483例接受非体外循环冠状动脉旁路移植术并使用基于左胸廓内动脉复合桥的患者。
  • SV组103例(大隐静脉作为第二或第三复合桥),ART组380例(全动脉复合桥),倾向性评分匹配后各103例。
  • 中位随访时间为128(97-139)个月。

主要发现

  • 匹配后两组手术死亡率和术后并发症发生率无差异。
  • 匹配后两组总体生存率和无心脏死亡生存率无差异(P = .369 和 P = .206),随访至术后12年。
  • 匹配后两组无再干预率和无主要心脑血管不良事件率相似(P = .695 和 P = .758),随访至术后12年。
  • 广义混合效应模型显示匹配后两组10年总体桥血管通畅率和复合桥血管通畅率无差异(P = .568 和 P = .702)。

临床怎么用

  • 在非体外循环CABG中,当需要复合桥时,大隐静脉复合桥可作为全动脉复合桥的等效替代选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We compared 10-year graft patency rates and long-term clinical outcomes after off-pump coronary artery bypass grafting using the saphenous vein composite grafts based on the left internal thoracic artery with those using total arterial composite grafts. METHODS: A total of 483 patients who underwent off-pump coronary artery bypass grafting using composite grafts based on the left internal thoracic artery were included. The saphenous vein was used as a second (connected to the left internal thoracic artery; n = 63) or a third (connected to the second arterial graft; n = 40) composite graft in 103 patients (SV group); total arterial composite grafting was performed in 380 patients (ART group). A propensity score-matched analysis was used to match the SV group to the ART group (n = 103 patients in each). The median follow-up duration was 128 (97-139) months. RESULTS: There were no differences in operative mortality and postoperative complication rates between the 2 matched groups. Propensity score-matched analyses showed no differences in the overall survival and freedom from cardiac death rates between the 2 groups (P = .369 and P = .206, respectively) up to 12 years after surgery. Freedom rates from reintervention and major adverse cardiac and cerebrovascular events were also similar between the 2 matched groups (P = .695 and P = .758, respectively) up to 12 years after surgery. Generalized mixed-effects models showed that the 2 matched groups demonstrated no differences in overall and composite graft patency rates during 10 years after surgery (P = .568 and P = .702, respectively). CONCLUSIONS: The saphenous vein composite grafts were equivalent to arterial composite grafts in terms of 10-year graft patency and long-term clinical outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Hwang HY, Lee Y, Sohn SH, et al. Equivalent 10-year angiographic and long-term clinical outcomes with saphenous vein composite grafts and arterial composite grafts. J Thorac Cardiovasc Surg. 2020. PMID: 32418633. doi:10.1016/j.jtcvs.2020.01.109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。